A study of histopathological assessment criteria for assessing malignancy of gastrointestinal stromal tumor, from a clinical standpoint

Journal of Gastroenterology

Volumn 40, Issue 5, 2005, Pages 467-473

  Yokoi, Kimiyoshi ^a   Tanaka, Noritake ^a   Shoji, Kyono ^a   Ishikawa, Noriyuki ^a   Seya, Tomoko ^a   Horiba, Koji ^a   Kanazawa, Yoshikazu ^a   Yamashita, Kiyohiko ^a   Ohaki, Yoshiharu ^a   Tajiri, Takashi ^b  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

GIST; Hemorrhage and necrosis; Ki 67; New criteria for malignancy; Tumor size

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; KI 67 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; NECROSIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR BLEEDING; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD34; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROTO-ONCOGENE PROTEINS C-KIT; REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 20444499471     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1571-6     Document Type: Article

References (34)

1. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27:625-41.
2. Goldblum JR. Gastrointestinal stromal tumors. A review of characteristic morphologic, immunohistochemical, and molecular genetic features. Am J Clin Pathol 2002(Suppl 1);117:S49-61.
3. Rosai J. Stromal tumors (GISTs and related lesions). In: Rosai J, editor. Rosai and Ackerman's surgical pathology. 9th ed. St. Louis: Mosby Year Book; 2004. p. 674-80.
4. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
5. Kitamura Y, Hirota S, Nishida T. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci 2003;94:315-20.
6. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 2003;54:3-24.
7. O'Leary T, Berman JJ. Gastrointestinal stromal tumors: Answers and questions. Hum Pathol 2002;33:456-8.
8. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-6.
9. Dematteo RP. The GIST of targeted cancer therapy: A tumor (gastrointestimal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 2002;9:831-9.
10. Tornoczky T, Kover E, Pajor L. Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours. J Clin Pathol 2003;56:363-7.
11. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377-89.
12. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immumohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947-55.
13. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993;100:428-32.
14. Miettinen M, El-Rifai W, Sobin LH, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review. Hum Pathol 2002;33:478-83.
15. Yokoi K, Tanaka N, Kyouno S, Ishikawa N, Tomoko S, Shirakawa T, et al. High efficacy of imatinib for recurrent gastrointestinal stromal tumor in the jejunum: A case report. J Nippon Med Sch 2004;71:114-9.
16. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-19.
17. Miettinen M, Virolainen M, Sarlomo-Rikala M. Gastrointestinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995;19:207-16.
18. Rossi CR, Mocellin S, Mencarelli R, Foletto M, Pilati P, Nitti D, et al. Gastrointestinal stromal tumors: From a surgical to a molecular approach. Int J Cancer 2003;107:171-6.
19. Yan H, Marchettini P, Acherman YI, Gething SA, Brun E, Sugarbaker PH. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol 2003;26:221-8.
20. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999;154:53-60.
21. Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002;20:3898-905.
22. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-9.
23. Bumming P, Andersson J, Meis-Kindblom JM, Klingenstierna H, Engstrom K, Stierner U, et al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A center-based study of 17 patients. Br J Cancer 2003;89: 460-4.
24. Wu PC, Langerman A, Ryan CW, Hart J, Swiger S, Posner MC. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003;134:656-65.
25. Langer C, Gunawan B, Schuler P, Huber W, Fuzesi L, Becker H. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003;90:332-9.
26. Kontogianni K, Demonakou M, Kavantzas N, Lazaris ACh, Lariou K, Vourlakou C, et al. Prognostic predictors of gastrointestinal stromal tumors: A multi-institutional analysis of 102 patients with definition of a prognostic index. Eur J Surg Oncol 2003;29:548-56.
27. Noguchi T, Sato T, Takeno S, Uchida Y, Kashima K, Yokoyama S, et al. Biological analysis of gastrointestinal stromal tumors. Oncol Rep 2002;9:1277-82.
28. Schneider-Stock R, Boltze C, Lasota J, Miettinen M, Peters B, Pross M, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 2003;21:1688-97.
29. Rosai J. Stromal tumors. In: Rosai J, editor. Ackerman's surgical pathology. 8th ed. St. Louis: Mosby Year Book; 1996. p. 645-7.
30. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-58.
31. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-65.
32. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160-5.
33. Wang X, Mori I, Tang W, Utsunomiya H, Nakamura M, Nakamura Y, et al. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST). Jpn J Clin Oncol 2002;32: 347-51.
34. Wong NA, Young R, Malcomson RD, Nayar AG, Jamieson LA, Save VE, et al. Prognostic indicators for gastrointestinal stromal tumours: A clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003;43:118-26.